Objectives:
To assess the diagnostic accuracy of PET-MRI and MRI alone for the detection of local recurrences of soft tissue sarcomas (STS) after initial surgical resection of the primary tumors.
IJ Radiology
To assess the diagnostic accuracy of PET-MRI and MRI alone for the detection of local recurrences of soft tissue sarcomas (STS) after initial surgical resection of the primary tumors.
A total of 41 patients with a clinically suspected tumor relapse of STS underwent an 18F-FDG- PET-MRI examination for assessment of local recurrence. Two experienced physicians interpreted the MRI data and subsequently the PET-MRI datasets in two separate reading sessions and were instructed to identify potential local tumor recurrences. Additionally, the diagnostic confidence in each reading for the identification of malignant lesions was determined. A McNemar test was applied to test for differences of both ratings and a Wilcoxon signed-rank test was used to identify differences of the confidence levels. Histopathological verification as well as follow-up imaging was applied as the standard of reference.
A tumor relapse was present in 27 / 41 patients. Calculated sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accurary for the detection of local tumor recurrence was 81%, 85%, 91%, 70%, 82% for MRI and 96%, 75%, 89%, 91%, 90% for PET-MRI (P > 0.05). Furthermore, PET/MRI showed significantly higher confidence levels (P < 0.05) for the determination of malignant lesions.
Our results demonstrate 18F-FDG PET-MRI to be an excellent imaging method in the evaluation of recurrent STS after surgical excision, as it displays superior detection accuracy as compared to routine MRI follow-up examinations.
© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Bakhshayeshkaram M, Aghahosseini F, Doroudinia A. The Role of 18F FDG PET/CT in Clinical Management of Breast Cancer; Additional Value Over Conventional Imaging Modalities. I J Radiol. 2017;14(Special Issue):e47975. doi: https://doi.org/10.5812/iranjradiol.47975
Daniels C, Wang W, Madewell JE, Wei W, Amini B. Pattern of Recurrence of Myxofibrosarcoma is not Associated with Pattern at Presentation or Rate of Delayed Diagnosis. I J Radiol. 2017;14(1):e13469. doi: https://doi.org/10.5812/iranjradiol.32548
Flechsig P, Zabeck H, Reubold S, Sachpekidis C, Rathke H, et al. Impact of FDG-PET and Dynamic Contrast-Enhanced MRI in Comparison with DWI for N-Staging in Lung Cancer Patients. I J Radiol. 2019;16(1):e68638. doi: https://doi.org/10.5812/iranjradiol.68638
Abedi M, Farrokh D, Homaei Shandiz F, Joulaee A, Anbiaee R, et al. The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. Int J Cancer Manag. 2013;6(1):e80382. doi:
Buyukdereli G, Aktar Y, Kara E, Uguz A, Sonmez H. Role of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Cytologically Indeterminate Thyroid Nodules. I J Radiol. 2016;13(1):e21186. doi: https://doi.org/10.5812/iranjradiol.21186
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCCÂ
Author(s):